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The major process limitations of current antibody purification processes are posed by affinity 
chromatography, although purification platforms based on affinity chromatography are very effective. 
Typically, protein A-based chromatography can account for more than 70% of downstream processing 
costs due to resin throughput, cost and complexity of scale up. Thus, there has been increased focus 
by the industry on developing and implementing continuous chromatography technology to increase 
resin capacity, reduce buffer consumption and increase productivity of packed bed steps. 
 
At UCB we have publicly presented a novel semi-continuous operation that can be operated on an 
unmodified chromatography skid named SCRAM (Sequential Chromatography Recycling with 
Asynchronous Multiplexing), which replicates the functionality and capacity gain of traditional 
continuous systems without the complexity. 
 
However, increasingly new innovative antibody formats have resulted in significant process platform 
adaptations to be performed prior to manufacture, and therefore the screening of many conditions to 
find a suitable window of operation may not be economically feasible at laboratory scale due to the 
amount of feedstream and resources required for each experiment. To overcome this issue, 
techniques that can generate data with minimal resource expenditure can be invaluable in early 
bioprocess development. Automated microscale platforms offer a change in bioprocess development 
by accelerating process development due to the flexibility for parallel experimentation and automation 
while requiring microscale quantities of material.  
 
In an industry first, we will demonstrate the application of SCRAM using 600 uL microscale columns 
on an automated robotic platform performed in parallel to explore large experimental design spaces 
with minimal resource expenditure. This has resulted in critical bioprocess information to be obtained 
earlier in development providing a better opportunity to understand process parameters and 
robustness understanding of this application. Therefore, this approach can be a viable and valuable 
alternative route for identifying sweet spots during screening studies in bioprocess development.  
 
Within the sector, automated high-throughput and miniaturised chromatographic process development 
relying on microscale columns is widespread, however, we believe this to be the first report of 
successful miniaturization of semi-continuous chromatography using microscale columns. 
 
 
 
 
 
 
 
